Nomogram to predict insignificant prostate cancer at radical prostatectomy in korean men: A multi-center study

Yonsei Medical Journal

Volumn 52, Issue 1, 2011, Pages 74-80

  Chung, Jae Seung ^a   Choi, Han Yong ^b   Song, Hae Ryoung ^c   Byun, Seok Soo ^d   Seo, Seong Il ^b   Song, Cheryn ^e   Cho, Jin Seon ^f   Lee, Sang Eun ^d   Ahn, Hanjong ^e   Lee, Eun Sik ^g   Hwang, Tae Kon ^h   Kim, Wun Jae ⁱ   Chung, Moon Kee ^j   Jung, Tae Young ^k   Yu, Ho Song ^a   Choi, Young Deuk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Hallym University College of Medicine   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

^h The Catholic University of Korea College of Medicine   (South Korea)

ⁱ Chungbuk National University College of Medicine   (South Korea)

^j Pusan National University   (South Korea)

^k Seoul Veterans Hospital   (South Korea)

more..

Author keywords

Insignificant; Nomograms; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BOOTSTRAPPING; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; ORGAN SIZE; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 78650539827     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.1.74     Document Type: Article

References (24)

1. Klein EA. What is 'insignificant' prostate carcinoma? Cancer 2004;101:1923-1925.
2. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol 2005;23:8165-8169.
3. Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170:1792-1797.
4. Nakanishi H, Wang X, Ochiai A, Trpkov K, Yilmaz A, Donnelly JB, et al. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer 2007;110:2441-2447.
5. Chun FK, Haese A, Ahyai SA, Walz J, Suardi N, Capitanio U, et al. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. Cancer 2008;113:701-709.
6. Shukla-Dave A, Hricak H, Scardino PT. Imaging low-risk prostate cancer. Curr Opin Urol 2008;18:78-86.
7. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-374.
8. Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 1998;160:2407-2411.
9. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994;8:439-443.
10. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-616.
11. Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics, 2002. CA Cancer J Clin 2002;52:23-47.
12. Steinberg GD, Bales GT, Brendler CB. An analysis of watchful waiting for clinically localized prostate cancer. J Urol 1998;159: 1431-1436.
13. Walsh PC. Surgery and the reduction of mortality from prostate cancer. N Engl J Med 2002;347:839-840.
14. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95:868-878.
15. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schröder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 2007; 177:107-112.
16. Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995;4:735-741.
17. Lee SE, Kwak C, Park MS, Lee CH, Kang W, Oh SJ. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population. Urology 2000;56:1007-1010.
18. Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer 2007;110:1255-1263.
19. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significant for treatment of prostate cancer. Cancer 1993;71:933-938.
20. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sözen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 1998;160:2412-2417.
21. Soh S, Kattan MW, Berkman S, Wheeler TM, Scardino PT. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 1997;157: 2212-2218.
22. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001;166: 104-109.
23. Lee HW, Seo SI, Jeon SS, Lee HM, Choi HY. Can we predict real T3 stage prostate cancer in patients with clinical T3 (cT3) disease before radical prostatectomy? Yonsei Med J 2010;51:700-707.
24. Humphrey PA, Vollmer RT. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol 1997;10:326-333.